Silver nanoparticles based on blackcurrant extract show potent anti-inflammatory effect in vitro and in DSS-induced colitis in mice.
Animals
Cell Survival
Colitis
/ drug therapy
Disease Models, Animal
Lipopolysaccharides
/ pharmacology
Male
Metal Nanoparticles
/ chemistry
Mice
Mice, Inbred BALB C
Particle Size
Peroxidase
/ metabolism
Plant Extracts
/ administration & dosage
RAW 264.7 Cells
Ribes
Silver
/ chemistry
Technology, Pharmaceutical
/ methods
Blackcurrant extract
Colitis
Inflammatory bowel diseases
RAW264.7 macrophages
Silver nanoparticles
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
30 Jul 2020
30 Jul 2020
Historique:
received:
09
05
2020
revised:
11
06
2020
accepted:
12
06
2020
pubmed:
20
6
2020
medline:
4
3
2021
entrez:
20
6
2020
Statut:
ppublish
Résumé
Silver nanoparticles have been used in a range of applications and although they are already employed in medicine, there are new, promising possibilities for their utilization. We investigated the potential of silver nanoparticles obtained with the use of blackcurrant extract in vitro in the LPS-stimulated RAW264.7 macrophages and in vivo in the murine DSS-induced colitis model. The examined formulations contained particles of 95 nm (Ag95) and 213 nm (Ag213) diameter. In vitro, both formulations inhibited nitric oxide (NO) release. In vivo, the preparations alleviated colitis as evidenced by a decreased macroscopic score and myeloperoxidase activity (indicative of neutrophil infiltration). In both cases, the nanoparticles of larger diameter showed better anti-inflammatory properties. Although further tests are required, our results indicate a plausible new use of silver nanoparticles in inflammatory bowel diseases.
Identifiants
pubmed: 32554032
pii: S0378-5173(20)30533-0
doi: 10.1016/j.ijpharm.2020.119549
pii:
doi:
Substances chimiques
Lipopolysaccharides
0
Plant Extracts
0
Silver
3M4G523W1G
Peroxidase
EC 1.11.1.7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119549Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.